-

Milliman Medical Index 20th anniversary edition: Healthcare costs for an American family reach $35,119 in 2025, increasing on average 6.1% annually since 2005

Pharmacy costs and outpatient facility care generate 69% of 2025 cost increase

SEATTLE--(BUSINESS WIRE)--Milliman, Inc., the premier global consulting and actuarial firm, today announced the release of the 2025 Milliman Medical Index (MMI), which measures healthcare costs for Americans covered by a typical employer-sponsored health insurance plan. Healthcare costs for the average person increased 6.7% in 2025, with pharmacy costs increasing by 9.7% and outpatient facility care costs rising 8.5%. Healthcare costs for a hypothetical family of four rose to $35,119.

“This year, outpatient facility services and pharmacy costs together accounted for nearly 70% of the total cost increase. Much of the outpatient growth is linked to high-cost drugs administered in outpatient settings.”

Share

“Pharmaceutical costs have been a leading driver of healthcare spending in recent years,” says Milliman Principal and Consulting Actuary Dave Liner. “This year, outpatient facility services and pharmacy costs together accounted for nearly 70% of the total cost increase. Much of the outpatient growth is linked to high-cost drugs administered in outpatient settings.”

In recognition of the MMI’s 20th anniversary, this edition includes a look back at how healthcare costs have evolved in the last 20 years.

“Since we began publishing the MMI 20 years ago, healthcare costs for American families have nearly tripled,” says Milliman Principal and Consulting Actuary Deana Bell. “Annual growth has averaged 6.1%, far outpacing any other household expense. No other cost category has risen as steeply or as consistently over the past two decades. Outpatient facility care saw the largest increase of any category, rising 286% since 2005, reflecting the growing complexity of procedures now handled outside of inpatient settings.”

Read this year’s MMI.

About Milliman

Milliman leverages deep expertise, actuarial rigor, and advanced technology to develop solutions for a world at risk. We help clients in the public and private sectors navigate urgent, complex challenges—from extreme weather and market volatility to financial insecurity and rising health costs—so they can meet their business, financial, and social objectives. Our solutions encompass insurance, financial services, healthcare, life sciences, and employee benefits. Founded in 1947, Milliman is an independent firm with offices in major cities around the globe. Visit us at milliman.com.

Contacts

Jeremy Engdahl-Johnson
Milliman, Inc.
Tel: +1 646.473.3021
Jeremy.engdahl-johnson@milliman.com

Milliman, Inc.


Release Summary
Milliman has just released its annual Milliman Medical Index which projects healthcare costs for an American family.
Release Versions

Contacts

Jeremy Engdahl-Johnson
Milliman, Inc.
Tel: +1 646.473.3021
Jeremy.engdahl-johnson@milliman.com

Social Media Profiles
More News From Milliman, Inc.

Milliman analysis: Public pension funding rises in October to highest level in study history

SEATTLE--(BUSINESS WIRE)--Milliman, Inc., a premier global consulting and actuarial firm, today released the latest results of its Public Pension Funding Index (PPFI), which analyzes data from the nation’s 100 largest public defined benefit plans. For the seventh straight month, the PPFI funded ratio improved in October, rising from 85.4% as of September 30 to 86.3% as of October 31, surpassing the previous high-water mark of 85.5% set at the end of 2021. Another month of strong investment retu...

Milliman CareFlowIQ Strengthens Real-Time Clinical Intelligence Platform with Expanded Medication History from Surescripts

SEATTLE--(BUSINESS WIRE)--Milliman CareFlowIQ™, transforming fragmented healthcare data into trusted, proven, evidence-based insights for informed decision-making, announces expanded medication reconciliation capabilities from Surescripts, the nation's leading health intelligence network. With Surescripts Medication History for Reconciliation, CareFlowIQ will give healthcare providers unprecedented access to comprehensive, real-time patient medication history. This data enhances whole-patient v...

Milliman analysis: Competitive pension risk transfer cost declines to 100.1% during October

SEATTLE--(BUSINESS WIRE)--Milliman, Inc., a premier global consulting and actuarial firm, today announced the latest results of its Milliman Pension Buyout Index (MPBI). During October, the estimated cost to transfer retiree pension risk to an insurer in a competitive bidding process decreased from 100.5% to 100.1% of a plan’s accounting liabilities (accumulated benefit obligation, or ABO). That means the estimated retiree PRT cost is now 100.1% of a plan’s ABO. During the same time period, the...
Back to Newsroom